Long‐term Evaluation of Type 2 Thyroplasty with Titanium Bridges for Adductor Spasmodic Dysphonia
Authors:
- 2 May 2017
- journal article
- research article
- Published by Wiley in Otolaryngology–Head and Neck Surgery
- Vol. 157 (1) , 80-84
Abstract
Objectives: Standard treatments of adductor spasmodic dysphonia (AdSD) provide temporary relief of symptoms. Type 2 thyroplasty offers a long‐term solution; however, long‐term voice outcome data are lacking. The objective of this study was to assess the long‐term voice outcomes of type 2 thyroplasty with titanium bridges through use of a validated voice questionnaire.Study Design: Case series with chart review.Setting: University hospital.Subjects and Methods: Forty‐seven consecutively enrolled patients with AdSD underwent type 2 thyroplasty with titanium bridges between August 2006 and November 2014. Questionnaires were completed during regularly scheduled follow‐ups and, in some cases, were sent to patients who missed follow‐up appointments. In 2015, questionnaires were mailed to all 47 patients and included a Voice Handicap Index–10 evaluation, as well as questions on postoperative vocal symptoms, surgical site, and status of the implanted titanium bridges.Results: Of 47 patients with AdSD, 31 (66%) completed the questionnaires. The average follow‐up interval was 41.3 months. No patient reported experiencing an adverse event around the surgical site, and almost all were satisfied with their voices postoperatively. The mean postoperative (>3 years) Voice Handicap Index–10 score improved significantly, from 26.3 to 9.4 (n = 17, P =. 0009).Conclusions: Type 2 thyroplasty for AdSD significantly improved patient quality of life and voice symptoms and continued to do so long after the surgery. The results of this study suggest that type 2 thyroplasty provides relief from vocal symptoms in patients with AdSD for >3 years.Keywords
Funding Information
- Japan Agency for Medical Research and Development
This publication has 17 references indexed in Scilit:
- Voice tuning with new instruments for type II thyroplasty in the treatment of adductor spasmodic dysphoniaAuris Nasus Larynx, 2016
- Nationwide Survey of Spasmodic Dysphonia in JapanThe Japan Journal of Logopedics and Phoniatrics, 2016
- Surgical tips for type II thyroplasty for adductor spasmodic dysphonia: modified technique after reviewing unsatisfactory casesActa Oto-Laryngologica, 2010
- Surgical treatment for adductor spasmodic dysphonia – efficacy of bilateral thyroarytenoid myectomy under microlaryngoscopyActa Oto-Laryngologica, 2008
- Contemporary management of spasmodic dysphoniaCurrent Opinion in Otolaryngology & Head and Neck Surgery, 2004
- Thyroplasty for Adductor Spasmodic Dysphonia: Further ExperiencesThe Laryngoscope, 2001
- Selective Laryngeal Adductor Denervationreinnervation: A New Surgical Treatment for Adductor Spasmodic DysphoniaAnnals of Otology, Rhinology & Laryngology, 1999
- Botulinum toxin management of spasmodic dysphonia (laryngeal dystonia): A 12‐year experience in more than 900 patientsThe Laryngoscope, 1998
- Adductor spastic dysphonia: Three years after recurrent laryngeal nerve resectionThe Laryngoscope, 1983
- Recurrent Laryngeal Nerve Section for Spastic DysphoniaAnnals of Otology, Rhinology & Laryngology, 1976